1. A transchromosomic rat model with human chromosome 21 shows robust Down syndrome features.
- Author
-
Kazuki Y, Gao FJ, Yamakawa M, Hirabayashi M, Kazuki K, Kajitani N, Miyagawa-Tomita S, Abe S, Sanbo M, Hara H, Kuniishi H, Ichisaka S, Hata Y, Koshima M, Takayama H, Takehara S, Nakayama Y, Hiratsuka M, Iida Y, Matsukura S, Noda N, Li Y, Moyer AJ, Cheng B, Singh N, Richtsmeier JT, Oshimura M, and Reeves RH
- Subjects
- Animals, Anxiety metabolism, Anxiety pathology, Cerebellum metabolism, Cerebellum pathology, Disease Models, Animal, Down Syndrome metabolism, Down Syndrome pathology, Female, Genes, Reporter, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Humans, Hyperkinesis metabolism, Hyperkinesis pathology, Karyotype, Learning, Male, Mutagenesis, Insertional, Organ Size, Posture, Prosencephalon metabolism, Prosencephalon pathology, Rats, Rats, Transgenic, Anxiety genetics, Chromosomes, Human, Pair 21, Down Syndrome genetics, Founder Effect, Hyperkinesis genetics
- Abstract
Progress in earlier detection and clinical management has increased life expectancy and quality of life in people with Down syndrome (DS). However, no drug has been approved to help individuals with DS live independently and fully. Although rat models could support more robust physiological, behavioral, and toxicology analysis than mouse models during preclinical validation, no DS rat model is available as a result of technical challenges. We developed a transchromosomic rat model of DS, TcHSA21rat, which contains a freely segregating, EGFP-inserted, human chromosome 21 (HSA21) with >93% of its protein-coding genes. RNA-seq of neonatal forebrains demonstrates that TcHSA21rat expresses HSA21 genes and has an imbalance in global gene expression. Using EGFP as a marker for trisomic cells, flow cytometry analyses of peripheral blood cells from 361 adult TcHSA21rat animals show that 81% of animals retain HSA21 in >80% of cells, the criterion for a "Down syndrome karyotype" in people. TcHSA21rat exhibits learning and memory deficits and shows increased anxiety and hyperactivity. TcHSA21rat recapitulates well-characterized DS brain morphology, including smaller brain volume and reduced cerebellar size. In addition, the rat model shows reduced cerebellar foliation, which is not observed in DS mouse models. Moreover, TcHSA21rat exhibits anomalies in craniofacial morphology, heart development, husbandry, and stature. TcHSA21rat is a robust DS animal model that can facilitate DS basic research and provide a unique tool for preclinical validation to accelerate DS drug development., Competing Interests: Declaration of interests M.O. is a CEO, employee, and shareholder of Trans Chromosomics, Inc., and S.A., H.T., and S.T. are employees of Trans Chromosomics, Inc. Other authors declare no conflicts of interest., (Copyright © 2021 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF